Question 1

What is Cornelia de Lange syndrome 2?

Accepted Answer

Cornelia de Lange syndrome 2 is an X-linked condition that affects multiple body systems, with a particular impact on cardiac and neurological development. It is caused by mutations in the SMC1A gene, which plays an important role in chromosome cohesion and gene regulation. Although individuals with this condition generally exhibit a milder form of the syndrome compared to other genetic causes, they may experience a range of symptoms, including heart-related issues and seizures. As precise birth prevalence data is not available, the condition is understood to be uncommon.

Question 2

What are the symptoms of Cornelia de Lange syndrome 2?

Accepted Answer

The clinical presentation of Cornelia de Lange syndrome 2 includes features affecting both the heart and the brain. Some affected individuals develop hypertrophic cardiomyopathy, while seizures are reported in a subset of cases. In addition, many children may experience developmental and intellectual challenges, and the condition has been associated with cognitive and neurological involvement. That not all individuals experience all features, and severity varies considerably.

Question 3

What causes Cornelia de Lange syndrome 2?

Accepted Answer

Cornelia de Lange syndrome 2 results from mutations in the SMC1A gene. The SMC1A gene encodes a protein that is a critical component of the cohesin complex, which is essential for maintaining proper chromosomal structure and regulating gene expression. This condition follows an X-linked dominant pattern, meaning that most cases arise from de novo pathogenic variants, so there is usually no prior family history. Female individuals are primarily affected, although due to variable X-inactivation their symptoms may vary, and affected individuals can pass the pathogenic variant to their offspring. Genetic counseling is recommended to discuss family planning and recurrence risk. Associated genes include SMC1A.

Question 4

How is Cornelia de Lange syndrome 2 inherited?

Accepted Answer

Cornelia de Lange syndrome 2 follows an X-linked inheritance pattern. Because the gene is located on the X chromosome, the condition may affect males and females differently.

Question 5

How is Cornelia de Lange syndrome 2 diagnosed?

Accepted Answer

Diagnosis is confirmed through molecular genetic testing identifying pathogenic variants in the SMC1A gene. A comprehensive clinical evaluation, including assessment of characteristic findings and a detailed family history, supports the diagnostic process. Because symptoms can overlap with other conditions, genetic testing is essential to reach a definitive diagnosis.

Question 6

Are there treatments for Cornelia de Lange syndrome 2?

Accepted Answer

Currently, management focuses on supportive care and symptom relief, as there are no approved treatments specifically for Cornelia de Lange syndrome 2. Treatment is tailored to the individual and typically involves a multidisciplinary team to address both cardiac concerns and neurological development. Regular surveillance is an essential part of long-term care, helping to identify potential complications early. Patients should discuss treatment options with their healthcare team to determine which therapies and supportive services may be most appropriate for their situation, and genetic counseling is recommended for all affected families.

Question 7

Are there clinical trials for Cornelia de Lange syndrome 2?

Accepted Answer

Yes, there is currently 1 active clinical trial for Cornelia de Lange syndrome 2 registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 8

Where can I find support for Cornelia de Lange syndrome 2?

Accepted Answer

Patient advocacy organizations for Cornelia de Lange syndrome 2 include Cornelia de Lange Syndrome Foundation, Inc.. These organizations can provide information, connect you with other families, and help navigate care. Visit the Support section of this page for full details and contact information.

Question 9

What are the potential complications of Cornelia de Lange syndrome 2?

Accepted Answer

Individuals with Cornelia de Lange syndrome 2 may face complications related to both cardiac and neurological health. Some may develop hypertrophic cardiomyopathy, which can affect heart function. Additionally, seizures can occur in some cases, and developmental and intellectual challenges are also common. Regular monitoring and support from healthcare providers can help manage these risks.

Question 10

How does Cornelia de Lange syndrome 2 affect daily life for individuals and families?

Accepted Answer

Living with Cornelia de Lange syndrome 2 can present unique challenges for individuals and their families. Many children may require additional support for developmental and intellectual challenges, which can impact education and social interactions. Families often work closely with a multidisciplinary team to address both cardiac and neurological needs, ensuring that their loved ones receive the care and resources they need.

Question 11

What is the life expectancy for someone with Cornelia de Lange syndrome 2?

Accepted Answer

The life expectancy for individuals with Cornelia de Lange syndrome 2 can vary widely and depends on the severity of symptoms and access to specialized care. With current standards of care, many individuals are living into adulthood and may experience periods of stability. Ongoing medical advancements and supportive care continue to improve outcomes for those affected by this condition.

Question 12

What specialists should families consult for managing Cornelia de Lange syndrome 2?

Accepted Answer

Families managing Cornelia de Lange syndrome 2 should consider consulting a team of specialists to address the various aspects of the condition. This may include cardiologists for heart-related issues and neurologists for cognitive and developmental support. Genetic counselors can also provide valuable information regarding family planning and recurrence risks, helping families navigate their options.

Organ System	Phenotype Count	Example Features
Brain and nerves	6	Poor speech, Seizure, Difficulty with thinking and memory (cognitive impairment)
Growth and development	3	Short stature, Postnatal growth retardation, Intrauterine growth retardation
Head and neck	3	Thin upper lip vermilion, High palate, Microcephaly
Arms and legs	2	Short foot, Small hand
Digestive system	1	Gastroesophageal reflux
Heart and blood vessels	1	Thickened heart muscle (hypertrophic cardiomyopathy)
Eyes	1	Ptosis

Feature	% of Persons w/Feature	Comment
Synophrys	98%1	In individuals w/classic features
Feeding difficulties	95%

Gene	Disorder	MOI	Features of Differential Disorder
CHOPS syndrome	AD	Cognitive impairment, heart defects, short stature, skeletal dysplasia	Coarse facial features, obesity, pulmonary involvement (features that are not typical for CdLS)1 ANKRD112
KBG syndrome

System/Concern	Evaluation	Comment
Constitutional	Measurement of growth parameters	CdLS-specific growth charts are available.1
Neurologic	Neurologic eval	Consider EEG if seizures are a concern.
Development	Developmental assessment	Motor, adaptive, cognitive, speech-language eval. Speech therapy is highly recommended to optimize communication skills should be implemented in 1st 18 mos of life.; Eval for early intervention/ special education
Behavioral	Neuropsychiatric eval	For persons age 12 mos: screen for concerns incl sleep disturbances, ADHD, anxiety, /or findings suggestive of ASD.
Musculoskeletal	Consider radiographs of upper extremities

Research Type	Count	% of Total
Patient case studies	8	44%
Research summaries	3	17%
Disease patterns and progression	3	17%
Laboratory research	2	11%
Testing and diagnosis research	1	6%
Clinical study results	1	6%

Cornelia de Lange syndrome 2

Overview

Clinical Presentation

Clinical Guidance

Explore clinical features

Genetic Landscape

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Differential Diagnosis

Treatment

Management Guidelines

Therapies Under Investigation

Clinical Trials

Prognosis

Surveillance Guidelines

Feeding

Gastrointestinal

Respiratory

Neurologic

Development

Behavioral

Musculoskeletal

Other

Dental

Hearing

Research Landscape

Recent Publications

Patient Support

Patient Advocacy Groups

Medical References

External Resources

OMIM

GARD

Related Diseases

Questions for Your Care Team